SelectedWorks - Peter D. Friedmann MD

Contact

Selected Works of Peter D. Friedmann MD

Chief Research Officer

Peter Friedmann, MD, MPH joined Baystate Health as its first Chief Research Officer on October 1, 2015

Works
About

×

About Peter D. Friedmann MD

Peter Friedmann, MD, MPH joined Baystate Health as its first Chief Research Officer on October 1, 2015

Present	Chief Research Officer, Baystate Health ‐ Division of Academic Affairs
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution

Cancel

Medicine and Health Sciences

The Leo M. Davidoff Society Award, "For Outstanding Achievement as a House Officer in the Teaching of Medical Students." Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY. 1990.
Primary Care Chief Resident. Montefiore Medical Center, Bronx, NY. 1990-1991.
New Investigator/Educator Award, Association for Medical Education and Research in Substance Abuse (AMERSA). 1999.
Generalist Physician Faculty Scholar Award, The Robert Wood Johnson Foundation. 2000-2004.
Mentor, HRSA-AMERSA-CSAT/SAMHSA Interdisciplinary Program to Improve Health Professional Education in Substance Abuse. 2000-2004.
Finalist, Junior Investigator of the Year, Society of General Internal Medicine. 2001.
Dean’s Teaching Excellence Award, Brown Medical School. In recognition of exemplary teaching in Bio 301: Clerkship in Medicine. 2001.
Best Workshop Award, PRIMECare: Promote Recovery in Medical Care. 25th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse, November 8, 2001.
Semi-finalist, Best Abstract Award, "Maintenance care for alcohol problems in remission in primary care." 26th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), November 7-9, 2002.
Bruce M. Selya Award for Research Excellence, Lifespan Hospitals, November 8, 2002
Mentor, ASAM Physician Clinical Support System (PCSS), a SAMHSA-funded network to support physicians prescribing buprenorphine. 2005- .
Member, American Society of Addiction Medicine’s Expert Review Panel “Quality Care Best Practice Models for the Treatment of Opioid Addiction Using Buprenorphine.” 2008.
Member, Expert Consensus Panel. “Performance Indicators for Prison Health Care,” RAND Corporation, Santa Monica, CA. July 21, 2009.
Distinguished Fellow, American Society of Addiction Medicine. 2010-.

Baystate Health Profile

Division of Academic Affairs

Baystate Health

280 Chestnut Street – 3rd Floor

Springfield, MA 01199

(413) 794-7324

Email:

Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts (Peter Friedmann) All Scholarly Works (2023)

Background: Carceral officials often cite diversion of medication for opioid use disorder (MOUD) (e.g., buprenorphine) as a reason for not offering MOUD treatment in jails and prisons with little understanding of patient perspectives. We aimed ...

Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities (Peter Friedmann) All Scholarly Works (2023)

Importance: Drug use and incarceration have a substantial impact on rural communities, but factors associated with the incarceration of rural people who use drugs (PWUD) have not been thoroughly investigated. Objective: To characterize associations between ...

"I would do anything but that": Attitudes towards sex work among rural people who use drugs (Peter Friedmann) All Scholarly Works (2023)

Background: Stigma towards people who use drugs and those who engage in sex work is well-documented, leading to consequences such as reduced access to health services and support, especially in rural milieus. Stigma reduction has ...

Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities (Peter Friedmann) All Scholarly Works (2023)

Background: People who inject drugs (PWID) in the rural U.S. often inject stimulants, alone or with opioids. The impact of these substance use patterns may influence HCV risk behaviors. This analysis examines the associations of ...

Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis (Peter Friedmann) All Scholarly Works (2023)

Background: Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe service program (SSP) use. However, ...

"I know my body better than anyone else": a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections (Peter Friedmann) All Scholarly Works (2023)

Background: People who inject drugs (PWID) are at risk for severe bacterial and fungal infections including skin and soft tissue infections, endocarditis, and osteomyelitis. PWID have high rates of self-directed discharge and are often not ...

Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians (Peter Friedmann) All Scholarly Works (2023)

Objectives: Overdose is a major cause of preventable death among persons living with HIV. This study aimed to increase HIV clinicians' naloxone prescribing, which can reduce overdose mortality. Methods: We enrolled 22 Ryan White-funded HIV ...

Screening Adolescents for Substance Use: a Four-Step Approach for Trainees (Peter Friedmann) All Scholarly Works (2023)

Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs (Peter Friedmann) All Scholarly Works (2023)

Background: Methamphetamine use is common among persons with opioid use disorder. This study evaluated associations between methamphetamine use and treatment with agonist medications for opioid use disorder (MOUD, specifically buprenorphine, and/or methadone) in U.S. rural ...

Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians (Peter Friedmann, Donna M Wilson and Randall Hoskinson) All Scholarly Works (2023)

Objectives: Overdose is a major cause of preventable death among persons living with HIV. This study aimed to increase HIV clinicians' naloxone prescribing, which can reduce overdose mortality. Methods: We enrolled 22 Ryan White-funded HIV ...

Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report (Benjamin Church, Ryan Clark, William Mohn, et al.) All Scholarly Works (2023)

In the era of illicit fentanyl, reports on difficulties with buprenorphine inductions for patients with opioid use disorder are emerging. Methadone is the only other approved medication treatment with efficacy similar to buprenorphine but without ...

"I am not a junkie": Social categorization and differentiation among people who use drugs (Peter Friedmann) All Scholarly Works (2023)

Background: Substance use stigma is a form of group-based exclusion, and delineating pathways from stigma to poor health requires a deeper understanding of the social dynamics of people who use drugs (PWUD). Outside of recovery, ...

COVID-19 impact on opioid overdose after jail release in Massachusetts (Peter Friedmann, Randall Hoskinson and Donna M Wilson) All Scholarly Works (2023)

Introduction: Release from incarceration is a high-risk period for opioid overdose. Concern about COVID-19 spread in jails led to early releases; it is unknown whether pandemic era releases of persons with opioid use disorder (OUD) ...

Parental substance use and home visiting programs: Implementation considerations for relationship-based treatment (Peter Friedmann and Elizabeth Peacock-Chambers) All Scholarly Works (2023)

Home visiting programs can provide critical support to mothers in recovery from substance use disorders (SUDs) and young children prenatally exposed to substances. However, families impacted by maternal SUDs may not benefit from traditional child-focused ...

Adaptation of an evidence-based parenting intervention for integration into maternal-child home-visiting programs: Challenges and solutions (Elizabeth Peacock-Chambers, Michael Moran, Maria Carolina Clark, et al.) All Scholarly Works (2023)

Background: The objective of this study was to assess potential challenges, prioritize adaptations, and develop an implementation and research approach to integrate and study a parenting intervention for mothers in recovery from substance use disorders ...

Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers (Peter Friedmann) All Scholarly Works (2023)

Introduction: Access to medications for opioid use disorder (MOUD) is limited for individuals in drug courts - programs that leverage sanctions for mandatory substance use treatment. Drug courts rely on community agencies to provide MOUD. ...

HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England (Peter Friedmann) All Scholarly Works (2023)

Background: Among people who inject drugs (PWID), obtaining syringes via syringe services programs (SSPs) and pharmacies reduces injection sharing practices associated with hepatitis C virus (HCV). Whether indirect use of SSPs via secondary exchange confers ...

Implementation Strategy Fidelity and Organizational Outcomes in a Randomized Trial: Implications for Reentry from Corrections to Community Treatment (Peter Friedmann) All Scholarly Works (2023)

Background: This study examined fidelity of implementation strategies used in an organizational process improvement intervention (OPII) designed to improve evidence-based practices related to assessments for drug-involved clients exiting incarceration. Leadership was studied as a moderating ...

Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report (Benjamin Church, Ryan Clark, William Mohn, et al.) All Scholarly Works (2022)

In the era of illicit fentanyl, reports on difficulties with buprenorphine inductions for patients with opioid use disorder are emerging. Methadone is the only other approved medication treatment with efficacy similar to buprenorphine but without ...

Health care professional perspectives on discharging hospitalized patients with injection drug use-associated infections (Peter Friedmann) All Scholarly Works (2022)

Background: Patients with injection drug use (IDU)-associated infections traditionally experience prolonged hospitalizations, which often result in negative experiences and bad outcomes. Harm reduction approaches that value patient autonomy and shared decision-making regarding outpatient treatment options ...

Preoperative alcohol interventions for elective surgical patients: Results from a randomized pilot trial (Peter Friedmann) All Scholarly Works (2022)

Background: High-risk alcohol use is a common surgical risk factor. Stopping or reducing alcohol use in the weeks before and after surgery could improve surgical health and outcomes. The purpose of this study was to ...

Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts (Peter Friedmann) All Scholarly Works (2022)

Background: Individuals with opioid use disorder released to communities after incarceration experience an elevated risk for overdose death. Massachusetts is the first state to mandate county jails to deliver all FDA approved medications for opioid ...

Relationship-Based Home Visiting Services for Families Affected by Substance Use Disorders: A Qualitative Study (Elizabeth Peacock-Chambers, Maria Carolina Clark and Peter Friedmann) All Scholarly Works (2022)

Home visiting programs face many challenges when providing evidence-based services to families affected by substance use disorders (SUDs). We conducted interviews and focus groups with community stakeholders and parents to elucidate important considerations when intentionally ...

Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers (Peter Friedmann) All Scholarly Works (2022)

Background: People released from jail are at elevated opioid overdose risk. Medications for opioid use disorder (MOUD) are effective in reducing overdoses. MOUD treatment was recently mandated in seven Massachusetts jails, but little is known ...

Relation of Patient's Opinion of Alcohol's Health Effects and Drinking Habits Among Hospitalized Patients With Cardiovascular Disease (Kyle Gobeil, Khalid Sawalha, Mohammed Abozenah, et al.) All Scholarly Works (2022)

Media reports frequently cite observational studies and meta-analyses to promote the reputed cardiovascular benefits of moderate alcohol consumption; however, it is unclear whether public opinion or drinking behavior align with these reports. We administered an ...